-

GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025.

Peter Arduini, president and CEO, GE HealthCare, said, “Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy.”

Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufacturing. She joins GE HealthCare from Alcon, where she served most recently as senior vice president and president, Global Franchises. In this role, she oversaw product development, portfolio management and commercialization of products across the global surgical, vision care, and ocular health businesses. Prior to Alcon, Bankes was at Boston Scientific and Merck, where she held a range of senior leadership positions.

Tom Westrick, who is retiring after more than 20 years with GE HealthCare, will remain with the company until May 31, 2025, to support Jeannette’s transition into the role, and help ensure a smooth changeover for our colleagues and customers. Jeannette will be based in Waukesha, Wisconsin.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

Contacts

GE HealthCare Media Contact:
Jennifer Fox
M 414-530-3027

GE HealthCare

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Media Contact:
Jennifer Fox
M 414-530-3027

More News From GE HealthCare

GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging

CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and...

GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced LOGIQ™ Focus, a new addition to its LOGIQ family of general imaging ultrasound systems, designed to bring advanced imaging tools to a broader range of ultrasound exams. LOGIQ Focus is a versatile ultrasound system that pairs high-quality LOGIQ imaging with AI-enabled, automation and productivity tools intended to support greater confidence, consistency and efficiency across routine and more complex care areas. "As demand for imaging grows,...

Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michiganiv evaluating the use of End-tidal Control software across a large multisite academic health system in Anesthesia & Analgesia Practice. The retrospective observational study analyzed 12,818 adult general anesthesia cases performed at University of Michigan Health – Ann Arbor locations between April 1, 2023 and September 30, 2024 on anesthesia machines wit...
Back to Newsroom